CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities:
Net loss	$ (550,978)	$ (422,877)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization (including impairments)	1,315,511	415,000
Equity in net loss of affiliates	4,122	0
Gain on investments, net	(188,788)	(58,634)
Loss on equity derivative contracts, net	137,507	27,345
Loss on extinguishment of debt and write-off of deferred financing costs	561,382	19,948
Amortization of deferred financing costs and discounts (premiums) on indebtedness	7,214	20,535
Settlement loss related to pension plan	389	0
Share-based compensation expense	25,927	0
Deferred income taxes	(308,390)	14,069
Excess tax benefit on share-based awards	0	82
Provision for doubtful accounts	32,918	13,338
Change in assets and liabilities, net of effects of acquisitions and dispositions:
Accounts receivable, trade	(8,006)	(31,330)
Other receivables	7,952	3,939
Prepaid expenses and other assets	(21,579)	(65,512)
Amounts due from and due to affiliates	(114,384)	3,700
Accounts payable	67,341	(8,599)
Accrued liabilities	(269,312)	278,782
Deferred revenue	10,614	3,473
Liabilities related to interest rate swap contracts	(8,500)	(40,241)
Net cash provided by operating activities	700,940	173,018
Cash flows from investing activities:
Payment for acquisition, net of cash acquired	(43,608)	(8,988,774)
Capital expenditures	(459,662)	(129,570)
Proceeds related to sale of equipment, including costs of disposal	1,536	970
Increase in other investments	(3,550)	0
Additions to other intangible assets	(744)	0
Net cash used in investing activities	(506,028)	(9,117,374)
Cash flows from financing activities:
Proceeds from credit facility debt	4,977,425	1,820,256
Repayment of credit facility debt	(3,573,750)	(3,995,927)
Proceeds from notes payable to affiliates and related parties	0	1,750,000
Proceeds from collateralized indebtedness	490,816	0
Repayment of collateralized indebtedness and related derivative contracts	(483,081)	0
Distributions to shareholders	(839,700)	0
Redemption of senior notes, including premiums and fees	(979,280)	0
Excess tax benefit on share-based awards	0	(82)
Principal payments on capital lease obligations	(8,061)	(5,849)
Additions to deferred financing costs	(7,352)	(12,396)
Proceeds from IPO, net of fees	349,156	0
Contributions from shareholders	1,135	1,200,973
Net cash provided by (used in) financing activities	(72,692)	756,975
Net increase (decrease) in cash and cash equivalents	122,220	(8,187,381)
Cash, cash equivalents and restricted cash at beginning of year	503,093	8,784,935
Cash, cash equivalents and restricted cash at end of period	$ 625,313	$ 597,554